, , ,

KLOW 80mg – Research Compound

£45.00

Currently out of stock (available to purchase on backorder). Estimated delivery for Backorders: 12th June 2026 (subject to change)

Quad-Peptide Regenerative Complex

KLOW 80mg

An advanced multi-pathway formulation combining BPC-157, GHK-Cu, TB-500, and KPV. This synergistic 80mg blend is extensively researched for its profound effects on tissue repair, angiogenesis, and targeted immune modulation.

KLOW Blend Vial
Molecular Engineering Data
Total Peptide Content80mg
Composition BreakdownGHK-Cu (50mg)
BPC-157 (10mg)
TB-500 (10mg)
KPV (10mg)
Primary MechanismMulti-Pathway Regeneration
Assay (HPLC)>99.0% Purity

Multi-Pathway Activation Cascade

KLOW represents a comprehensive approach to biological repair. By combining four distinct mechanisms into a single protocol, researchers can observe simultaneous activation of extracellular matrix remodeling, actin sequestration, and NF-kB suppression. This creates a highly optimized environment for studying accelerated cellular recovery in complex trauma models.

TISSUE
Vascular Repair (BPC-157 & TB-500)

TB-500 regulates actin polymerization to enhance cell migration, while BPC-157 rapidly accelerates the repair of soft tissue and gastrointestinal lining.

IMMUNE
Remodeling & Balance (GHK-Cu & KPV)

GHK-Cu drives robust collagen synthesis and extracellular matrix repair. KPV concurrently targets the NF-kB pathway to mitigate localized and systemic inflammation.

Structural Blueprint

The 80mg formulation utilizes a precisely balanced ratio to prevent competitive binding while maximizing synergy. GHK-Cu (50mg) provides the structural foundation for cellular remodeling, supported by 10mg each of BPC-157, TB-500, and KPV to address acute physical stress and systemic inflammatory responses.

KLOW Peptide Structures

Pharmacological Benchmarks
  • Base Origin: Synergistic Peptide Blend
  • Primary Action: Comprehensive Tissue Restoration
  • Tissue Repair: Soft Tissue & GI Integrity
  • Inflammation: Targeted NF-kB & Cytokine Reduction
  • Cellular Target: Extracellular Matrix & Immune Cells

Key Research Benchmarks

In preclinical models, the KLOW blend is extensively investigated for its targeted effects on Complex Wound Healing and Systemic Inflammation. Researchers map the rapid interaction of these four peptides to determine their volumetric efficacy in reversing severe tissue necrosis and immune dysregulation.

Structural Remodeling
Observing the rapid deposition of collagen and elastin fibers alongside enhanced cellular motility in models of severe musculoskeletal trauma.
Inflammatory Modulation
Analysis of profound reductions in pro-inflammatory cytokines, protecting newly formed cellular structures from secondary oxidative damage.

Laboratory Protocol & Handling
Storage & Stability
Supplied lyophilised for maximum sequence integrity during logistics.

  • Dry Storage: -20°C for >12 months; 2-8°C for <6 months.
  • Liquid Stability: Must be refrigerated (2-8°C) once reconstituted.
  • Solubility: Sterile Bacteriostatic Water or PBS.
Reconstitution SOP
Strict adherence to laboratory SOPs is required to maintain the stability of all four sequences in solution.

  • Solvent: Sterile Bacteriostatic Water or PBS.
  • Technique: Slow sidewall induction; do not agitate the puck.
  • Unit Sizes: 80mg precision research configurations.

Strict Laboratory Compliance Notice

WARNING: This compound is a chemical reagent supplied exclusively for in-vitro and in-vivo laboratory research. It is NOT a drug, medication, or food supplement. Strictly prohibited for human or veterinary administration. Lawful handling is the sole responsibility of the professional user. HRS Distribution assumes no liability for applications outside of laboratory scientific research.

© 2026 | HRS DISTRIBUTION | UK DISPATCHED

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

You may also like…

Shopping Cart
KLOW 80mg - Research CompoundKLOW 80mg – Research Compound
£45.00

Currently out of stock (available to purchase on backorder). Estimated delivery for Backorders: 12th June 2026 (subject to change)

Scroll to Top